The stock of LifeMD Inc. (NASDAQ:LFMD) last traded at $1.84, up 0.17% from the previous session.
Data from the available sources indicates that LifeMD Inc. (NASDAQ:LFMD) is covered by 1 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $8.00 and a low of $8.00, we find $8.00. Given the previous closing price of $1.84, this indicates a potential upside of 334.78 percent. LFMD stock price is now -16.94% away from the 50-day moving average and -20.66% away from the 200-day moving average. The market capitalization of the company currently stands at $58.51M.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
In total, 0 analysts have assigned it a hold rating, and 1 have given it a buy rating. Brokers who have rated the stock have averaged $8.00 as their price target over the next twelve months.
With the price target of $14, Colliers Securities recently initiated with Buy rating for LifeMD Inc. (NASDAQ: LFMD).
In other news, BHATIA NAVEEN, Director bought 50,000 shares of the company’s stock on May 18. The stock was bought for $106,800 at an average price of $2.14. Upon completion of the transaction, the Director now directly owns 246,349 shares in the company, valued at $0.45 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 14, General Counsel & CCO Yecies Eric Harold bought 5,000 shares of the business’s stock. A total of $15,700 was incurred on buying the stock at an average price of $3.14. This leaves the insider owning 51,000 shares of the company worth $93840.0. Insiders disposed of 60,000 shares of company stock worth roughly $0.11 million over the past 1 year. A total of 0.20% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in LFMD stock. A new stake in LifeMD Inc. shares was purchased by MAI CAPITAL MANAGEMENT during the first quarter worth $184,000. BANK OF NEW YORK MELLON CORP invested $60,000 in shares of LFMD during the first quarter. In the first quarter, CHARLES SCHWAB INVESTMENT MANAGEMENT INC acquired a new stake in LifeMD Inc. valued at approximately $37,000. WOLVERINE TRADING, LLC acquired a new stake in LFMD for approximately $22,000. In total, there are 51 active investors with 18.50% ownership of the company’s stock.
With an opening price of $1.8570 on Tuesday morning, LifeMD Inc. (NASDAQ: LFMD) set off the trading day. During the past 12 months, LifeMD Inc. has had a low of $1.72 and a high of $4.32. The fifty day moving average price for LFMD is $2.2154 and a two-hundred day moving average price translates $2.3191 for the stock.
The latest earnings results from LifeMD Inc. (NASDAQ: LFMD) was released for Jun, 2022. According to the Pharmaceutical Retailers Company, earnings per share came in at -$0.45, missing analysts’ expectations of -$0.35 by -0.1. This compares to -$0.54 EPS in the same period last year. The net profit margin was -46.40% and return on equity was -565.30% for LFMD. The company reported revenue of $31.41 million for the quarter, compared to $24.95 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 25.92 percent. For the current quarter, analysts expect LFMD to generate $31.84M in revenue.
LifeMD Inc.(LFMD) Company Profile
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men’s sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men’s telehealth brand that offers virtual medical treatment from licensed providers for a variety of men’s health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as.offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
